Refine by
Depressive Symptoms Articles & Analysis
11 news found
With the advancement of biotechnology and biological tools, such as diagnostic technology and animal model development, researchers can further investigate the mechanisms related to depression and thereby develop effective therapies targeting depression. ...
Regular intake has been demonstrated to reduce symptoms of depression and anxiety, enhance fetal brain development, and lower heart disease risks by managing cholesterol and blood pressure levels. ...
Anxiety and depression affect millions of individuals worldwide, leading to a significant burden on public health and impacting overall quality of life. Depression is commonly seen in neurodegenerative and neurodevelopmental diseases such as Alzheimer's disease, Parkinson's disease, Huntington's disease, and autism spectrum disorders. ...
Zuranolone 50 mg demonstrated a clinically meaningful and statistically significant improvement in depressive symptoms at Day 15, the primary endpoint, and at Days 3, 28, and 45, key secondary endpoints as previously reported Newly presented data offered additional insight into the SKYLARK Study and further demonstrated the rapid improvements in ...
In patients who completed 1 year of follow-up in both cohorts of the SHORELINE Study (n=407), most had minimal or mild depressive symptoms at study exit as assessed by the Clinical Global Impressions-Severity scale. ...
The study’s primary endpoint will assess changes in depressive symptoms, from baseline to 8 weeks post-treatment initiation when using Relivion DP, compared to the control group, in subjects suffering from MDD. The severity of depressive symptoms will be assessed by the Hamilton Rating Scale for Depression. ...
The survey was conducted online by The Harris Poll during August 2021 on behalf of Alkermes, Inc., a subsidiary of Alkermes plc (Nasdaq: ALKS), and in collaboration with the Depression and Bipolar Support Alliance (DBSA), a not-for-profit organization that provides support to people who live with depression and bipolar disorder, as well as to their friends and ...
ByAlkermes
By using the words people say and how they say them, the company has pioneered an artificial intelligence-powered, speech-based vital sign to identify, quantify and manage depression, and anxiety symptoms at scale. Its integrated behavioral health solution aids time-strapped healthcare providers (frontline workers, PCPs, case managers, nurses, etc.) and payers to ...
The direct ECG response of the Coala Heart Monitor contributed to reduced levels of anxiety, depression and symptoms of palpitations. The direct ECG response of the Coala also led to an increased quality of life (HRQOL). ...
A 2015 study found that “CBD has considerable potential as a treatment for multiple anxiety disorders,” including generalized anxiety disorder, panic disorder, and social anxiety disorder. May help improve symptoms of depression. CBD has antidepressant qualities, most likely related to how it interacts with the brain’s serotonin receptors to ...
ByMedcbdx
In addition, patients can suffer associated non-motor symptoms such as difficulty sleeping, memory loss, anxiety and depression. Whilst these symptoms can initially be managed with medication, there is currently no treatment available that effectively prevents disease progression, or that treats the motor and non-motor symptoms ...